Comparison of olanzapine and quetiapine antipsychotic treatments of schizophrenia: 6-month results from the 3-year intercontinental schizophrenia outpatient health outcomes (IC-SOHO) observational study

被引：0
|
作者：
Morrison, S
O'Halloran, RA
Boland, J
Dossenbach, M
Mahuad, R
Gastiaburu, CO
机构：
来源：
AUSTRALIAN AND NEW ZEALAND JOURNAL OF PSYCHIATRY | 2003年 / 37卷
关键词：
D O I：
暂无
中图分类号：
R749 [精神病学];
学科分类号：
100205 ;
摘要：
引用
收藏
页码：A12 / A13
页数：2
相关论文
共 50 条
  • [31] The Schizophrenia Outpatient Health Outcomes (SOHO) study:: 3-year results of antipsychotic treatment discontinuation and related clinical factors in Spain
    Ciudad, Antonio
    Haro, Josep Maria
    Alonso, Jordi
    Bousono, Manuel
    Suarez, David
    Novick, Diego
    Gilaberte, Inmaculada
    [J]. EUROPEAN PSYCHIATRY, 2008, 23 (01) : 1 - 7
  • [32] Effects of antipsychotic treatment on tardive dyskinesia: A 6-month evaluation of patients from the European Schizophrenia Outpatient Health Outcomes (SOHO) study
    Tenback, DE
    van Harten, PN
    Slooff, CJ
    Belger, MA
    van Os, J
    [J]. JOURNAL OF CLINICAL PSYCHIATRY, 2005, 66 (09) : 1130 - 1133
  • [33] Tolerability of outpatient antipsychotic treatment:: 36-Month results from the European Schizophrenia Outpatient Health Outcomes (SOHO) study
    Novick, D.
    Haro, J. M.
    Suarez, D.
    Bushe, C.
    Lepine, J. P.
    [J]. INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY, 2006, 9 : S161 - S161
  • [34] Tolerability of outpatient antipsychotic treatment: 36-month results from the European Schizophrenia Outpatient Health Outcomes (SOHO) study
    Novick, Diego
    Maria Haro, Josep
    Perrin, Elena
    Suarez, David
    Texeira, Joao Marques
    [J]. EUROPEAN NEUROPSYCHOPHARMACOLOGY, 2009, 19 (08) : 542 - 550
  • [35] Outpatient treatment initiation with olanzapine or risperidone: Results from the schizophrenia outpatient health outcomes (SOHO) study
    Edgell, ET
    Frewer, P
    Haro, JM
    Novick, D
    [J]. SCHIZOPHRENIA RESEARCH, 2002, 53 (03) : 184 - 185
  • [36] Antipsychotic treatment discontinuation in the outpatient treatment for schizophrenia: 24-month results from the Pan-European SOHO (schizophrenia outpatient health outcomes) study
    Novick, D
    [J]. BIOLOGICAL PSYCHIATRY, 2005, 57 (08) : 71S - 71S
  • [37] Atypical antipsychotic treatment patterns: Results from the Schizophrenia Outpatient Health Outcomes (SOHO) study
    Edgell, ET
    Frewer, P
    Haro, JM
    Perahia, D
    Wright, P
    [J]. JOURNAL OF PSYCHOPHARMACOLOGY, 2002, 16 (03) : A19 - A19
  • [38] Antipsychotic treatment discontinuation in the outpatient treatment for schizophrenia: 24-month results from the pan-European SOHO (schizophrenia outpatient health outcomes) study
    Haro, J
    Novick, D
    Belger, M
    Tzivelekis, S
    Murray, D
    Texeira, JM
    Alonso, J
    Bousono, MG
    Gasquet, I
    Kristensen, H
    Jones, PB
    Croudace, T
    Knapp, M
    Lepine, JP
    Mavreas, V
    Naber, D
    Pancheri, P
    Slooff, CJ
    [J]. SCHIZOPHRENIA BULLETIN, 2005, 31 (02) : 486 - 486
  • [39] Predictors of antipsychotic treatment continuation in the outpatient setting: 12-month results from the Schizophrenia Outpatient Health Outcomes (SOHO) study
    Haro, JM
    Novick, D
    Belger, M
    Tzivelekis, S
    Ratcliffe, M
    [J]. INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY, 2004, 7 : S233 - S234
  • [40] Gender differences in schizophrenia:: Results from the schizophrenia Outpatient Health Outcomes Study (SOHO)
    Haro, JM
    Gasquet, I
    Lépine, JP
    Edgell, ET
    Frewer, P
    Novick, D
    Usall, J
    [J]. SCHIZOPHRENIA RESEARCH, 2003, 60 (01) : 285 - 285
12345